Fortress Biotech (FBIO) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $0.73.
- Fortress Biotech's Debt to Equity rose 11779.14% to $0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.73, marking a year-over-year increase of 11779.14%. This contributed to the annual value of $2.55 for FY2024, which is 556.4% down from last year.
- According to the latest figures from Q3 2025, Fortress Biotech's Debt to Equity is $0.73, which was up 11779.14% from $1.14 recorded in Q2 2025.
- In the past 5 years, Fortress Biotech's Debt to Equity ranged from a high of $4.54 in Q1 2023 and a low of -$15.6 during Q1 2024
- For the 5-year period, Fortress Biotech's Debt to Equity averaged around -$0.67, with its median value being $0.44 (2022).
- Over the last 5 years, Fortress Biotech's Debt to Equity had its largest YoY gain of 93413.56% in 2023, and its largest YoY loss of 59057.03% in 2023.
- Quarter analysis of 5 years shows Fortress Biotech's Debt to Equity stood at $0.19 in 2021, then surged by 864.64% to $1.83 in 2022, then skyrocketed by 47.21% to $2.7 in 2023, then decreased by 5.56% to $2.55 in 2024, then crashed by 71.25% to $0.73 in 2025.
- Its Debt to Equity was $0.73 in Q3 2025, compared to $1.14 in Q2 2025 and $1.74 in Q1 2025.